HIROBRIZ

This brand name is authorized in Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland

Active ingredients

The drug HIROBRIZ contains one active pharmaceutical ingredient (API):

1 Indacaterol UNII 2JEC1ITX7R - INDACATEROL MALEATE

Indacaterol is a partial agonist at the human beta2-adrenergic receptor with nanomolar potency. When inhaled, indacaterol acts locally in the lung as a bronchodilator. In isolated human bronchus, indacaterol has a rapid onset of action and a long duration of action. Read about Indacaterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AC18	Indacaterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1452259, 1452260, 1452271, 1452282, 1452293, 1452305, 1452316, 1452327, 1452338, 1452349
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09594002, 09594007
Country: IT	Agenzia del Farmaco	Identifier(s): 039699018, 039699020, 039699032, 039699044, 039699057, 039699069, 039699071, 039699083, 039699095, 039699107
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1052624, 1052625, 1052626, 1052627, 1052628, 1052629, 1052630, 1052631, 1052632, 1052633
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 92347, 92355
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100248613, 100248719